Keywords: Roche, Cellcept, organ transplant drugs, FDA

FDA calls for warning on Roche’s Cellcept

Article | 17 August 2009

Print This

The US Food and Drug Administration has called for the label of Swiss drug major Roche’s Cellcept (mycophenolate mofetil) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in